Towards a taxonomy of judicialisation for access to medicines in Latin America

References

• Acosta, A., & Falcão, M. (2019). Judicialización del acceso a medicamentos en el contexto suramericano. Revista De Direito Sanitário, 1(20), 36–62. doi:https://doi.org/10.11606/issn.2316-9044
   Google Scholar
• Aleman, A., & Perez Galan, A. (2017). Impact of health technology assessment in litigation concerning access to high-cost drugs. International Journal of Technology Assessment in Health Care, 33(4), 411–414. https://doi.org/https://doi.org/10.1017/S0266462317000575
   PubMed Web of Science ®Google Scholar
• Andia, O. (2019). Las causas de la crisis financiera del sistema de salud colombiano desde los medicamentos. Revista de la Universidad Industrial de Santander. Salud, 51(4), 277–278. https://doi.org/https://doi.org/10.18273/revsal.v51n4-2019009
   Google Scholar
• Andia, T. S., & Lamprea, E. (2019). Is the judicialization of health care bad for equity? A scoping review. International Journal for Equity in Health, 18(1), 61–70. https://doi.org/https://doi.org/10.1186/s12939-019-0961-y
   PubMedGoogle Scholar
• Backman, G., Hunt, P., Khosla, R., Jaramillo-Strouss, C., Fikre, B. M., Rumble, C., Pevalin, D., Páez, D. A., Pineda, M. A., Frisancho, A., Tarco, D., Motlagh, M., Farcasanu, D., & Vladescu, C. (2008). Health systems and the right to health: An assessment of 194 countries. The Lancet, 372(9655), 2047–2085. https://doi.org/https://doi.org/10.1016/S0140-6736(08)61781-X
   PubMed Web of Science ®Google Scholar
• Berardo, M. D. (2019). La accion de amparo como medio idoneo para obtener tratamientos de alto costo. Revista de la Facultad de Derecho, UBA, 10(2), 201–216.
   Google Scholar
• Biehl, J., Socal, M., & Amon, J. J. (2016). The judicialization of health and the quest for state accountability: Evidence from 1,262 lawsuits for access to medicines in southern Brazil. Health and Human Rights, 1(18), 209–2017.
   Google Scholar
• Borges, D. (2018). Individual healthcare litigation and HR, strengthening the role of HTA in Brasil. Health and Human Rights, 1(20), 147–151.
   Google Scholar
• Borges, D., & Dominguez Uga, M. (2005). Conflitos e impasses da judicializacao na otencao de medicamentos: as decissoes de primeira instancia nas acoes individuais contra o Estado de Rio de Janeiro, Brasil, em. Cadernos de Saude Publica, 26(4), 59–69.
   Google Scholar
• Braccamonte, S. (2020, June 16). Pharma Baires. Obtenido de Judicialización De La Salud En Argentina Y América Latina. http://www.pharmabaires.com/1651-judicializacion-de-la-salud-en-argentina-y-america-latina.html.
   Google Scholar
• Brasil, CNJ. (2019). JUDICIALIZAÇÃO DA SAÚDE NO BRASIL: PERFIL DAS DEMANDAS, CAUSAS E PROPOSTAS DE SOLUÇÃO. Conselho Nacional de Justica.
   Google Scholar
• Briant, P., & Altuna, J. (2016). Implicancias socioeconómicas de la utilizacion de instrumentos judiciales para la prestacion de bienes y servicios sanitario. Buenos Aires, Superintendencia de Servicios de Salud.
   Google Scholar
• Burguin-Drago, M. (2013). El amparo judicial como instrumento de ampliacion del PMO - El estado nacional como garante de la Salud [Tesis Doctoral]. Editorial Fundacion Sanatorio Guemes, Buenos Aires, Argentina.
   Google Scholar
• Cardenas, J. (2018). Algunas reflexiones sobre judicializacion y acceso a medicamentos: el caso de Brasil y Mexico. En Libreria de Derecho de la Universidad Nacional de Mexico (UNAM) Reflexiones sobre judicializacion (pp. 269–282). Universidad Nacional de Mexico.
   Google Scholar
• Casson, S., & Ruiz, F. J. (2013). How long has NICE taken to produce technology appraisal guidance? A retrospective study to estimate predictors of time to guidance. BMJ Open, 3(1), e001870. https://doi.org/https://doi.org/10.1136/bmjopen-2012-001870
   PubMed Web of Science ®Google Scholar
• Castro, K. (2012). Os NAT como instrumento de aperfeicoamento das decisoes judiciais na area da saude. Fundacion Getulio Vargas – Direito RIO.
   Google Scholar
• Catanheide, I., Lisboa, E., & Souza, L. (2016). Características da judicialização do acesso a medicamentos no Brasil: uma revisão sistemática. Physis: Revista de Saúde Coletiva, 26(4), 1335–1356. https://doi.org/https://doi.org/10.1590/s0103-73312016000400014
   Google Scholar
• Cobo-Armijo, F., Charvel, S., & Pelcastre-Villafuerte, B.. (2020). La judicializacion del derecho a la proteccion de la salud desde la optica de los actores clave. Salud Publica de Mexico. doi:https://doi.org/10.21149/10491
   Google Scholar
• Cruz, J. (2019, 2 13). Corte Suprema versus Ricarte Soto – Una aproximación a la judicialización de remedios de alto costo. Santiago – see https://observatoriojudicial.org/equipo/: Observatorio Judicial – informe 15. Recuperado el 3 24, 2020, de http://www.observatoriojudicial.org/corte-suprema-versus-ricarte-soto/.
   Google Scholar
• Daniels, N. (2007). Just health: Meeting health needs fairly. Cambridge University Press.
   Google Scholar
• Daniels, N., Charvel, S., Gelpi, A. H., Porteny, T., Urrutia, J., & Perez, K. (2015). Role of the courts in the progressive realization of the right to health: Between the threat and the promise of judicialization in Mexico. Health Systems & Reform, 1(3), 229–234. https://doi.org/https://doi.org/10.1080/23288604.2014.1002705
   PubMed Web of Science ®Google Scholar
• Defensoria del pueblo de Colombia. (2020). La tutela y los derechos a la salud y la seguridad social. D. C. 14th edition. www.defensoria.gov.co.
   Google Scholar
• Estado de la Justicia. (2019). Judicialización de la salud: recursos de amparo por medicamentos – chapter 6. Gobierno de Costa Rica.
   Google Scholar
• Evaluate-Pharma. (2017). 4th edition, forecast 2017-2022 orphan drug report. Evaluate Pharma.
   Google Scholar
• Ferrario, A., & Kanavos, P. (2015). Dealing with uncertainty and high prices of new medicines: A comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science & Medicine, 124, 39–47. https://doi.org/https://doi.org/10.1016/j.socscimed.2014.11.003
   PubMed Web of Science ®Google Scholar
• Ferraz, O. L. (2018). Health in the courts of Latin America. Health and Human Rights, 20(1), 67–74.
   PubMed Web of Science ®Google Scholar
• Flood, C., & Gross, A. (2014). Litigating the right to health: What can we learn from a comparative law and health care systems approach. Health and Human Rights Journal, 16(2), 62–72.
   PubMed Web of Science ®Google Scholar
• Florio, M. (2014). Judicializacion de la Salud; Prestaciones no incluidas en el PMO. Auditoria Hospital Aleman Buenos Aires, Argentina. Curso Presencial.
   Google Scholar
• Forman, L. (2008). Justice and justiciability: Advancing solidarity and justice through South Africans’ right to health jurisprudence. Medicine and Law 27, 661–683.
   PubMedGoogle Scholar
• Freiberg, A., Lafferriere, J. N., & Zambrano, M. (2019). Agnet y judicialization en Salud en Argentina. VHRI 20(1), 36–40. https://doi.org/https://doi.org/10.1016/j.vhri.2018.11.003
   Google Scholar
• Freitas, B., Fonseca, E., & Dagmar, D. P. (2020). A Judicialização da saúde nos sistemas público e privado de saúde: uma revisão sistemática. Interface – Comunicação, Saúde, Educação, 24, e190345. https://doi.org/https://doi.org/10.1590/interface.190345
   Google Scholar
• Gallegos Zúñiga, J. (2012). Políticas públicas desarrolladas recientemente en Chile en materia de derecho a la salud, en particular respecto al acceso a los medicamentos y su natural incidencia en la propiedad intelectual. Repositorio Universidad Nacional de Chile, 33(16), 233–242.
   Google Scholar
• Garbozza, J. (2018). A judicialização e a gestão das políticas públicas: Um estudo sobre as demandas judiciais que pleiteiam o fornecimento de medicamentos do poder executivo municipal de Caçador/SC. Universidade Tecnológica Federal Do Paraná.
   Google Scholar
• Giedion, U., & Bitrán, R. (2014). Health benefit plans in Latin America: A regional comparison. Inter-American Development Bank.
   Google Scholar
• Gotlieb, V., Yavich, N., & Bascolo, E.. (2016). Litigio judicial y el Derecho a la Salud en Argentina. Cadernos de Saude Publica, 32, e00121114.
   Google Scholar
• Harker, J., & Kleijnen, J. (2012). What is a rapid review? A methodological exploration of rapid reviews in health technology assessments. International Journal of Evidence-Based Healthcare, 10(4), 397–410. https://doi.org/https://doi.org/10.1111/j.1744-1609.2012.00290.x
   PubMedGoogle Scholar
• IDSI. (2017). Healthcare priority setting in the courts: A reflection on decision-making when healthcare priority setting is brought to court. F1000Research, 6. F1000 Research.
   Google Scholar
• Iunes, R., Cubillos, L., & Escobar, M. (2012). Universal health coverage and litigation in Latin America. World Bank – n 178.
   Google Scholar
• Iunes, R., Littlejohns, P., Weale, A., Chalkidou, K., Teerwattananon, Y., Faden, R., & Escobar, M. (2012). Universal health coverage and litigation in Latin America. Journal of Health Organization and Management, 26(3), 12–19. https://www.emerald.com/insight/content/doi/10. 1108/14777261211239034/full/html
   Google Scholar
• Manikowski, R. (2018). Acceso A Medicación De Alto Costo En Uruguay. Bioderecho, (8), 7–14. https://doi.org/https://doi.org/10.6018/bioderecho.366041
   Google Scholar
• Mayer-Serra, C., & Núñez, L. (2019). ¿ Más derechos para todos? Derechos humanos, políticas públicas y el caso de los medicamentos huérfanos. Cuestiones Constitucionales 40, 353–384. https://doi.org/https://doi.org/10.22201/iij.24484881e.2019.40.13237
   Google Scholar
• Mosegui, G., & Antoñanzas, F. (2019). Regulations on expanded access and compassionate use of medicines in South America. Revista Panamericana de Salud Pública, 43, e57–e65. https://doi.org/https://doi.org/10.26633/RPSP.2019.57
   PubMed Web of Science ®Google Scholar
• Muños, B. (2019, January 14). 2018 New drug approvals, an All-time record and a watershed. (Forbes Magazine) Recuperado el 5 12, 2020, de Forbes Technology. www.forbes.com/sites/bernardmunos/2019/01/14/2018-new-drugs-approvals-an-all-time-record
   Google Scholar
• Norheim, O., & Wilson, B. (2014). Health rights litigation and access to medicines: Priority classification of successful cases from Costa Rica’s Constitutional Chamber of the Supreme Court. HHR, 16(2), 47–54.
   Google Scholar
• PAHO. (2020). Conversatorio interinstitucional; judicialización de los medicamentos de alto precio en Uruguay. Organizacion Panamericana de la Salud – MINSAL Uruguay.
   Google Scholar
• Pichon-Riviere, A., Garay, O., Augustovski, F., Vallejos, C., Huayanay, L., Navia Bueno, M., & Drummond, M. (2015). Implications of global pricing policies on access to innovative drugs: The case of trastuzumab in seven Latin American countries. International Journal of Technology Assessment in Health Care, 31(1), 2–11. https://doi.org/https://doi.org/10.1017/S0266462315000094
   PubMed Web of Science ®Google Scholar
• Pinzón-Flórez, C., & Cubillos, L. (2016). Priorización de estrategias para el abordaje de la judicialización en salud en América Latina y el Caribe. Revista de Saúde Pública, 56(50), 1–14. https://doi.org/https://doi.org/10.1590/S1518-8787.2016050005728
   Google Scholar
• Pizzarossa, L., & Perehudoff, K. (2018). How the Uruguayan judiciary shapes access to high-priced medicines: A critique through the right to health lens. Health and Human Rights, 20(1), 93–105.
   PubMed Web of Science ®Google Scholar
• Rawlins, M., Appleby, J., & Timmins, N. (2016). A terrible beauty “a history of NICE”. HiTAP – Prince Mahidol Award Conference 2016 and WHO CO for Thailand.
   Google Scholar
• Román Forastelli, M. (2014). Judicialización de la salud: Revisión de los recursos de amparo relacionados con medicamentos. PRIMER INFORME ESTADO DE LA JUSTICIA – PEN CONARE SCIJ.
   Google Scholar
• Sabadzija, A. (2019). La judicialización de la salud pública en la Argentina. DS: Derecho y Salud, 29(1), 232–243.
   Google Scholar
• Silva, R., Lima, E., Novaes, M., & Osorio, C. (2020). The high “cost” of experimental drugs obtained through health litigation in Brazil. Frontiers in Pharmacology, 11, 752–757. https://doi.org/https://doi.org/10.3389/fphar.2020.00752
   PubMed Web of Science ®Google Scholar
• Syrett, K. (2018). Evolving the right to health: Rethinking the normative response to problems of judicialization health and human rights. Health and Human Rights, 20(1), 121–126.
   PubMed Web of Science ®Google Scholar
• Teodoro, C., Caetano, R., Godman, B., dos Reis, A., Maia, A., Ramos, M., & Osorio-de-Castro, C. (2017). Federal procurement of unlicensed medicines in Brazil; findings and implications. Expert Review of Pharmacoeconomics & Outcomes, 17(6), 2–12. https://doi.org/https://doi.org/10.1080/14737167.2017.1311209
   Web of Science ®Google Scholar
• UNAM. (2016). Amparo en revision – 350/2014 – Universidad Nacional de Mexico. Biblioteca Juridica Virtual del Instituto de Investigaciones Juridicas de la UNAM – Suprema Corte de Justicia de la Nacion.
   Google Scholar
• Uruguay Presidencia. (2019, June 26). Fondo Nacional de Recursos pasó de no otorgar ningún medicamento de alto precio en 2004 a más de 7.800 en 2018. (estadisticas FNR) Recuperado el 6 14, 2020, de https://presidencia.gub.uy/comunicacion/comunicacionnoticias/fnr-medicacion-alto-precio-alicia-ferreira-2004-cero-cobertura-2018-7835-modelo-unico-mundo.
   Google Scholar
• Vargas López, K. (2019). La experiencia de costa rica en relacion con la judicialización de la medicina. XL asamblea ordinaria del consejo de instituciones de seguridad social de centro américa y república dominicana (pág. original PPT presentation), Antigua, Guatemala. 20 de Marzo del 2019. https://cdn.cisscad.org/wp-content/uploads/2019/03/22181554/La-experiencia-de-Costa-Rica-en-relacion-con-la-judicializacion-de-la-medicina.pdf
   Google Scholar
• Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., Gyansa-Lutterodt, M., Jing, S., Luiza, V. L., Mbindyo, R. M., & Möller, H. (2017). Essential medicines for universal health coverage. The Lancet, 389(10067), 403–476. https://doi.org/https://doi.org/10.1016/S0140-6736(16)31599-9
   PubMed Web of Science ®Google Scholar
• World Bank. (2021, January 18). Domestic general government health expenditure per capita, PPP (current international $). Obtenido de World Health Organization Global Health Expenditure database (apps.who.int/nha/database). https://data.worldbank.org/indicator/SH.XPD.GHED.PP.CD?most_recent_value_desc=true.
   Google Scholar
• Yamauti, S., Barreto, J., Barberato-Filho, S., & Lopes, L. (2020). Strategies implemented by public institutions to approach the judicialization of health care in Brazil: A systematic scoping review. Frontiers in Pharmacology, 11, 1128–1135. https://doi.org/https://doi.org/10.3389/fphar.2020.01128
   PubMed Web of Science ®Google Scholar
• Yamin, A. (2019). The right to health in Latin America: The challenges of constructing fair limits. Legal Scholarship Repository; Penn Law, and Harvard School of Law.
   Google Scholar